DUBLIN--(BUSINESS WIRE)--The "8th Annual Biomarker and Companion Diagnostics Conference" conference has been added to ResearchAndMarkets.com's offering.
Leveraging next-gen technologies beyond conventional biomarker drug discovery!
The hosts bring to you the 8th Annual Biomarker and CDx Conference scheduled to be held on 8th - 9th February 2023 in San Diego, USA. This event will have an introduction to turning biomarkers into companion diagnostics.
30+ experts from academia and industry will be presenting their current work in Biomarkers, the latest updates on regulatory guidelines and approvals, Cancer biomarker validation for clinical application, Biomarkers and Personalized Medicine, the Impact of Big data in translational biomarker research and the Future of Companion Diagnostics
Opportunity to develop long-lasting business relationships and networking opportunities with researchers, scientists, clinicians, academicians and professionals from Pharmaceutical companies, Bio-pharma companies, Universities, and Research institutes.
Over 20 presentations, round tables, and panel discussions focused on the key opportunities and challenges in biomarker research, from precision medicine and companion diagnostics through to digital biomarkers and clinical trials.
The Expert Panel will take you through their presentations which will include problems, solutions and services in the Clinical Applications of Biomarkers in Immuno-Oncology, Neurology and Inflammatory Diseases. Attendees would evidence the examples and the case studies which will help in creating the revenue. The keynote presentations would also help the attendees understand the issues related to clinical translation of biomarkers.
What To Expect
Key Highlights
- Commercialization of CDx
- Proteomics and Genomics based Biomarkers
- Biomarker Drug Discovery and Assay Development
- Multiplex Companion Diagnostics and Regulatory Guidelines
- Design of clinical trials in CDx
- Digital Biomarkers, Predictive Biomarkers, Precision Medicine and Big Data
- Clinical Applications of Biomarkers in Immuno-Oncology, Neurology and Inflammatory Diseases
Who Should Attend:
Researchers, scientists, clinicians, academicians and professionals from Pharmaceutical companies, Bio-pharma companies & Universities and Research institutes working in:
- Biomarker discovery/development
- Translational research
- Clinical Biomarker
- Biomarkers in IO and Neurological disorders
- Imaging Biomarkers
- Pathology
- Companion Diagnostics
- Biomarker Imaging
- Proteomics Biomarkers
- Experimental Medicine
- Data Science
- Biomarkers in Clinical Discovery
- Immuno-oncology/Neuroscience Drug Discovery
- Diagnostic Biomarkers development
- Personalized Medicine
- Immunology Biomarkers
Agenda:
Day 1 Wed, 08-Feb-2023
Registration
08:15 - 08:45
Welcome note
08:45 - 09:05
Opening Remarks from the Chairman
09:05 - 09:10
Keynote Presentation
09:10 - 09:40
Challenges associated with Clinical Biomarker Validation
Advancing Digital Pathology in biomarker identification and drug discovery
09:40 - 10:10
Solution Provider Presentation-Reserved for Gold Sponsor
10:10 - 10:25
Morning Refreshments and Poster Presentation - One-to-One Networking Meetings
10:25 - 11:10
Non-invasive biomarker identification and analysis using Breath Biopsy
11:10 - 11:40 Huw Davies, VP, Global Sales, Owlstone Medical
Presentation by BD Biosciences
11:40 - 12:10
Studying the clinical change of paradigm in liquid biopsies
12:10 - 12:40
Use of biomarkers in clinics-success and challenges of getting a good biomarker
12:40 - 13:10
Lunch and Poster Presentation - One-to-One Networking Meetings
13:10 - 14:10
Role of Biomarkers in Personalized Medicine
Precision Oncology Centric Development of Antibody Drug Conjugates
14:10 - 14:40 Rakesh Dixit, CEO, Bionavigen
Solution Provider Presentation
14:40 - 14:55
Why is monitoring predictive biomarker data so difficult for big pharma?
14:55 - 15:25
AI for proteomics and biomarker discovery
15:25 - 15:55
Afternoon Refreshments and Poster Presentation - One-to-One Networking Meetings
15:55 - 16:40
Patient Identification and Stratification applying predictive models
16:40 - 17:10
Use of Real World Evidence in the discovery of digital biomarkers
17:10 - 17:25
Solution Provider Presentation
17:25 - 17:55
Closing Remarks from the Chairman
17:55 - 17:55
Drinks Reception & Networking
17:55 - 17:55
End of Day 1
17:55 - 17:55
Day 2 Thu, 09-Feb-2023
Registration
08:15 - 09:00
Welcome note
09:00 - 09:05
Opening Remarks from the Chairman
09:05 - 09:10
Keynote Presentation
09:10 - 09:40
From Biomarkers to CDx: Strategies to accelerate CDx development and Commercialization
From Undruggable Target to CDx and Beyond
09:40 - 10:10 Mason Israel, Regional Medical Affairs Director, Mirati Therapeutics
Solution Provider Presentation-Reserved for Gold Sponsor
10:10 - 10:25
Morning Refreshments and Poster Presentation - One-to-One Networking Meetings
10:25 - 11:10
Future of RNA Diagnostics in Cancer
11:10 - 11:40 Michael Milburn, President, CEO, GeneCentric Therapeutics
Solution Provider Presentation-Reserved for Silver Sponsor
11:40 - 11:55
CDx Launch Success: From Early Biomarker Development to Commercialization
11:55 - 12:10
Solution Provider Presentation
12:10 - 12:40
Building up a successful CDx partnership with Pharma
12:40 - 13:10
Lunch and Poster Presentation - One-to-One Networking Meetings
13:10 - 14:10
Clinical Applications of Biomarkers in Immuno-Oncology, Neurology, and Infectious Diseases
Solution Provider Presentation
14:10 - 14:25
Leveraging IO markers for companion diagnostics development
14:25 - 14:55
Solution Provider Presentation
14:55 - 15:25
Innovative Safety Biomarker Applications to Drug Development
15:25 - 15:55
End of Conference
15:55 - 15:55
Speakers
Maria Wang
Associate Director, Bristol-Myers Squibb
Yingpeng Zhan
Scientist, Sorrento Therapeutics
Michael Milburn
President, CEO, GeneCentric Therapeutics
Rakesh Dixit
CEO, Bionavigen
Mason Israel
Regional Medical Affairs Director, Mirati Therapeutics
Matthew Davis
Director, Molecular Biology and Sequencing, Gritstone Oncology
Huw Davies
VP, Global Sales, Owlstone Medical
Senior Representative, BD Biosciences
For more information about this conference visit https://www.researchandmarkets.com/r/lwpsu7
